MSLENasdaqPharmaceutical PreparationsFiscal year ends December 31
Satellos Bioscience Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 27, 2026
$6.44−0.02 (-0.31%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Satellos Bioscience has not reported a dividend
No dividend per share appears in Satellos Bioscience's annual filings since fiscal 2023.